Article Details

The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third ...

Retrieved on: 2019-12-12 21:07:30

Tags for this article:

Click the tags to see associated articles and topics

The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third .... View article details on HISWAI:

Excerpt

<div><b>Applied DNA Sciences</b> Inc (NASDAQ: APDN)'s fourth-quarter revenue climbed 40% year-over-year to $1.7 million. The net loss narrowed from $4.62 ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up